Board of Directors

Dr. Katrina Dipple is a Professor at the University of Washington, Department of Pediatrics in the Division of Genetic Medicine. She also serves as the Medical Director of Genetic Medicine at Seattle Children’s Hospital. Her clinical work focuses on pediatric genetics.

Dr. Peter Hulick is the Janardan D. Khandekar, MD, Chair of Personalized Medicine and Division Head for Medical Genetics at Endeavor Health. He also serves as Clinical Associate Professor at the University of Chicago Pritzer School of Medicine. He has authored or co-authored more than 70 peer reviewed journal articles and book chapters. His clinical interests include apply genomic information to prevention, diagnosis and treatment of human disease with a focus on implementation of genomics guided care throughout Endeavor Health.

Dr. Myra Wick is a Consultant and Associate Professor of OBGYN and Clinical Genomics at Mayo Clinic Rochester. Her clinical interests include care of complex obstetrical patients, prenatal diagnostics and diagnosis and care of patients with GYN associated hereditary cancer syndromes.

Dr. Colleen Jackson-Cook is a Professor of Pathology, Human & Molecular Genetics, and Obstetrics & Gynecology at Virginia Commonwealth University in Richmond, where she serves as the Director of the Molecular Cytogenetics Diagnostic Laboratory and Program Director for the Laboratory Genetics and Genomics Fellowship. Her research and clinical interests include mosaic and non-mosaic Down syndrome and acquired cytosolic, telomeric, and epigenetic changes acquired with aging.

Ms. Carol Clothier spent more than 28 years providing communications, strategic planning, policy and advocacy support to physician regulatory organizations. Most recently she served as Vice President, State Health Policy and Public Affairs for the American Board of Medical Specialties (ABMS), providing strategic leadership and operational oversight of the organization’s programs to influence the policy positions of state legislatures, medical boards and physician groups.

Dr. Kristina Cusmano-Ozog is a Clinical Associate Professor of Pathology at Stanford University School of Medicine, where she also serves as Director of the Clinical Biochemical Genetics Laboratory. Her clinical research focuses on expanding the molecular, biochemical, and clinical phenotypes of rare disorders including those identified by newborn screening, with a special emphasis on underrepresented populations.

Dr. Natasha Frank is a Clinical Geneticist and a Physician-Scientist in the Division of Genetics at Brigham and Women’s Hospital and VA Boston Healthcare System. She serves as Director of the Harvard Medical School Genetics Training Program at its BWH and VA sites and as an NIH- and VA-funded physician-scientist investigating rare disorders through the Undiagnosed Disease Network. Her research endeavors are focused on dissecting the relationship of multipotent stem cells residing in diverse human tissues to genetic diseases and cancer.

Dr. Madhuri Hegde is a Clinical Molecular Geneticist and is the Senior Vice President and Chief Scientific Officer of Revvity Inc. She is the head of global laboratory services. She also is an Adjunct Professor of Pediatrics and Genetics at Emory University School of Medicine. The focus of her clinical work is the development and implementation of high-throughput strategies for discovery and clinical testing for rare and common disorders.

Dr. Rong Mao is a Professor of Pathology at the University of Utah School of Medicine and Medical Director of Molecular Genetics and Genomics in ARUP Laboratories.  She is also co-director of the Laboratory Genetics and Genomics (LGG) Fellowship. Her clinical interests include the genotype-phenotype correlations in inborn errors of metabolism and genetic diseases in the RAS/MAPK pathway, and she continues work with implementing Next-Generation Sequencing (NGS) techniques into molecular diagnostics.

Dr. Melissa Merideth is a clinical and biochemical geneticist and obstetrician/gynecologist at the Clinical Center of the National Institutes of Health (NIH) in Bethesda, Maryland. She serves as the Program Director of the NIH Medical Biochemical Genetics and Clinical Biochemical Genetics fellowship programs. Her scientific interests include expanding the gynecologic phenotype of patients with rare diseases and genetic syndromes as well as residency education and resident wellness. She serves as Chair of the ACGME Review Committee for Medical Genetics and Genomics.

Dr. Nathaniel Robin is a Professor and Clinical Division Director in the Department of Genetics at the Heersink/ University of Alabama at Birmingham School of Medicine, and the Director of Clinical Genetics and Genomics Services at UAB Medicine. He is an active clinical geneticist with a focus on craniofacial genetics. Dr. Robin served as Chair of the Board’s Clinical Exam committee in the past.

Dr. Katie Rudd is a Medical Director in Cytogenetics and Genomic Microarray at ARUP Laboratories and an Adjunct Professor in the Department of Pathology at the University of Utah. She is fascinated by chromosomes and has authored over 40 publications on genomic structural variation. She also serves as the Book Chief for the ABMGG General Exam and In-Training Exam.

Dr. Margarita Saenz is an Associate Professor of Clinical Practice at Children’s Hospital Colorado in conjunction with the University of Colorado Anschutz Medical Campus. Her clinical interests include neurogenetics, brain malformation, intractable epilepsies, Rett syndrome, as well as novel therapeutics in Precision Medicine.

Dr. J. Daniel Sharer is a Professor of Genetics at the University of Alabama at Birmingham (UAB) Heersink School of Medicine, where he specializes in Biochemical Genetics. He previously served as Secretary of the ABMGG Board and as a member of the Executive Committee.

Dr. Alpa Sidhu is a Clinical Associate Professor of Pediatrics at the University of Iowa Health Care in Iowa City, Iowa. Dr. Sidhu serves as the Clinical Director for the Division of Medical Genetics and Genomics and as the Program Director for both the Categorial and Combined Pediatrics and Medical Genetics and Genomics residency training program. Dr. Sidhu’s clinical and research interests include tumor predisposition syndromes and lysosomal storage disorders.

Dr. Erin Strovel is Associate Professor in the Department of Pathology at the University of Maryland School of Medicine. She is the Director of the Biochemical Genetics Laboratory, which serves as an NHGRI/NIH ACGME-accredited medical genetics and genomics fellowship rotation site. She is also very involved in medical and graduate education, currently serving as the embedded content lead for genetics in the pre-clerkship curriculum and as course director for a basic human genetics course for first year graduate students.

Dr. Akila Subramaniam is an Associate Professor in the Division of Maternal-Fetal Medicine (MFM) program at the University of Alabama at Birmingham (UAB). Dr. Subramaniam is currently the Director of the UAB OB/GYN Diagnostic and Research laboratory and the Program Director of the MFM fellowship. She also is PI of two multi-center childhood follow-up studies of the landmark Cesarean Section and Optimal Antibiotic Prophylaxis (C/SOAP) trial. With her broad background, Dr. Subramaniam’s clinical interests include fetal ultrasound, prenatal genetic diagnosis, and complicated twin pregnancies. Her research interests include perinatal infections and preterm birth.

Dr. Azra Ligon is Associate Professor of Pathology at Harvard Medical School. Her current appointments include Co-Director of the Brigham and Women’s Hospital (BWH) Center for Advanced Molecular Diagnostics and Division Chief of Clinical Cytogenetics at BWH Dr. Ligon’s research interests involve the study of the genomics of primary brain tumors using molecular genetic and cytogenetic techniques.